Clinical Applications of Artificial Neural Networks in Pharmacokinetic Modeling
暂无分享,去创建一个
[1] S. Agatonovic-Kustrin,et al. Application of artificial neural networks in HPLC method development. , 1998, Journal of pharmaceutical and biomedical analysis.
[2] Abbas Sheikhtaheri,et al. Developing and Using Expert Systems and Neural Networks in Medicine: A Review on Benefits and Challenges , 2014, Journal of Medical Systems.
[3] S. Hu,et al. Artificial neural networks aided deconvolving overlapped peaks in chromatograms. , 1996, Journal of chromatography. A.
[4] Davide Verotta,et al. Pharmacokinetic–Pharmacodynamic Modelling: History and Perspectives , 2006, Journal of Pharmacokinetics and Pharmacodynamics.
[5] S. Agatonovic-Kustrin,et al. ANN modeling of the penetration across a polydimethylsiloxane membrane from theoretically derived molecular descriptors. , 2001, Journal of pharmaceutical and biomedical analysis.
[6] J Bourquin,et al. Application of artificial neural networks (ANN) in the development of solid dosage forms. , 1997, Pharmaceutical development and technology.
[7] Eric A. Wan,et al. Finite impulse response neural networks with applications in time series prediction , 1994 .
[8] Arjpolson Pukrittayakamee,et al. Practical Training Framework for Fitting a Function and Its Derivatives , 2011, IEEE Transactions on Neural Networks.
[9] Young-Sang Choi,et al. Quantitative Structure-Activity Relationships (QSAR) Study of Flavonoid Derivatives for Inhibition of Cytochrome P450 1A2 , 2000 .
[10] Johann Gasteiger,et al. Neural networks and genetic algorithms in drug design , 2001 .
[11] Ajaz S. Hussain,et al. Modeling the Pharmacokinetics and Pharmacodynamics of a Unique Oral Hypoglycemic Agent Using Neural Networks , 2004, Pharmaceutical Research.
[12] D. Maddalena,et al. Applications of soft computing in drug design , 1998 .
[13] David W. A. Bourne,et al. Mathematical Modeling of Pharmacokinetic Data , 1995 .
[14] Antonio J. Serrano,et al. Prediction of cyclosporine dosage in patients after kidney transplantation using neural networks , 2003, IEEE Transactions on Biomedical Engineering.
[15] Leon Shargel,et al. Applied biopharmaceutics and pharmacokinetics , 1980 .
[16] D. Butina,et al. Predicting ADME properties in silico: methods and models. , 2002, Drug discovery today.
[17] Mohammad I. Saleh,et al. Dosage Individualization of Warfarin Using Artificial Neural Networks , 2014, Molecular Diagnosis & Therapy.
[18] Peter Veng-Pedersen,et al. Neural networks in pharmacodynamic modeling. Is current modeling practice of complex kinetic systems at a dead end? , 1992, Journal of Pharmacokinetics and Biopharmaceutics.
[19] J. Topliss,et al. Chance factors in studies of quantitative structure-activity relationships. , 1979, Journal of medicinal chemistry.
[20] Jie Chen,et al. Use of artificial neural network to predict warfarin individualized dosage regime in Chinese patients receiving low-intensity anticoagulation after heart valve replacement. , 2014, International journal of cardiology.
[21] Marek Wesolowski,et al. Artificial neural networks: theoretical background and pharmaceutical applications: a review. , 2012, Journal of AOAC International.
[22] L P Balant,et al. Modelling during drug development. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[23] Hsinchun Chen,et al. Estimating drug/plasma concentration levels by applying neural networks to pharmacokinetic data sets , 2000, Decis. Support Syst..
[24] H. Metting,et al. Neural networks in high-performance liquid chromatography optimization: response surface modeling. , 1996, Journal of chromatography. A.
[25] S. Agatonovic-Kustrin,et al. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. , 2000, Journal of pharmaceutical and biomedical analysis.
[26] D J Roe,et al. Application of neural networks to population pharmacokinetic data analysis. , 1997, Journal of pharmaceutical sciences.
[27] Antonio J. Serrano,et al. Some Examples for Solving Clinical Problems Using Neural Networks , 2001, IWANN.
[28] P. Veng‐Pedersen,et al. Quantitative structure-pharmacokinetic relationships for systemic drug distribution kinetics not confined to a congeneric series. , 1994, Journal of pharmaceutical sciences.
[29] Brian D. Ripley,et al. Pattern Recognition and Neural Networks , 1996 .
[30] Y. Pathak,et al. Artificial Neural Network in Drug Delivery and Pharmaceutical Research , 2013 .
[31] E Holmes,et al. Quantitative structure-metabolism relationships (QSMR) using computational chemistry: pattern recognition analysis and statistical prediction of phase II conjugation reactions of substituted benzoic acids in the rat. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.
[32] M. Burnier,et al. Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness? , 2006, BMC nephrology.
[33] Jasper Dingemanse,et al. Integrated Pharmacokinetics and Pharmacodynamics in Drug Development , 2007, Clinical pharmacokinetics.
[34] Jonas S Almeida,et al. Predictive non-linear modeling of complex data by artificial neural networks. , 2002, Current opinion in biotechnology.
[35] K J Schaper,et al. Quantitative structure-pharmacokinetic relationships and drug design. , 1981, Pharmacology & therapeutics.
[36] Application of neural networks for the prediction of human pharmacokinetic parameters. , 1995, Methods and findings in experimental and clinical pharmacology.
[37] H Ichikawa,et al. Neural networks applied to quantitative structure-activity relationship analysis. , 1990, Journal of medicinal chemistry.
[38] L. Snyder,et al. Computer simulation for the prediction of separation as a function of pH for reversed-phase high-performance liquid chromatography. I. Accuracy of a theory-based model. , 1992, Journal of chromatography.
[39] T Nagai,et al. Formula optimization based on artificial neural networks in transdermal drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[40] J. Taskinen,et al. Neural network modeling for estimation of the aqueous solubility of structurally related drugs. , 1997, Journal of pharmaceutical sciences.
[41] G. Camps,et al. Artificial neural networks for the classification of potentially intoxicated patients treated with digoxin , 2000, Proceedings of the 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (Cat. No.00CH37143).
[42] James L. McClelland. Explorations In Parallel Distributed Processing , 1988 .
[43] J A Dowell,et al. Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience. , 1999, Journal of pharmaceutical sciences.
[44] S. K. Singh,et al. QUANTITATIVE STRUCTURE PHARMACOKINETIC RELATIONSHIP USING ARTIFICIAL NEURAL NETWORK: A REVIEW , 2009 .
[45] F. Huang,et al. Assessment of chromatographic peak purity by means of artificial neural networks. , 1996, Journal of chromatography. A.
[46] Neil Davey,et al. The application and limitations of mathematical modelling in the prediction of permeability across mammalian skin and polydimethylsiloxane membranes , 2011, The Journal of pharmacy and pharmacology.
[47] Shigeo Yamamura,et al. Clinical application of artificial neural network (ANN) modeling to predict pharmacokinetic parameters of severely ill patients. , 2003, Advanced drug delivery reviews.
[48] T. Rades,et al. Use of artificial neural networks to predict quaternery phase systems from limited experimental data. , 1999, Journal of pharmaceutical and biomedical analysis.
[49] M Tusar,et al. Viscosity prediction of lipophilic semisolid emulsion systems by neural network modelling. , 2000, International journal of pharmaceutics.
[50] A Bucinski,et al. Pharmacological classification of drugs based on neural network processing of molecular modeling data. , 2000, Combinatorial chemistry & high throughput screening.
[51] K. Behbehani,et al. An artificial neural network-based controller for the control of induced paralysis using vecuronium bromide , 1997, Annals of Biomedical Engineering.
[52] J V Gobburu,et al. Artificial neural networks as a novel approach to integrated pharmacokinetic-pharmacodynamic analysis. , 1996, Journal of pharmaceutical sciences.
[53] T Lavé,et al. Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques. , 1999, Journal of medicinal chemistry.